These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9930860

  • 1. Remembering MOG: autoantibody mediated demyelination in multiple sclerosis?
    Wekerle H.
    Nat Med; 1999 Feb; 5(2):153-4. PubMed ID: 9930860
    [No Abstract] [Full Text] [Related]

  • 2. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP, Cannella B, Hauser SL, Raine CS.
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [Abstract] [Full Text] [Related]

  • 3. Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis.
    McFarland HI, Lobito AA, Johnson MM, Nyswaner JT, Frank JA, Palardy GR, Tresser N, Genain CP, Mueller JP, Matis LA, Lenardo MJ.
    J Immunol; 1999 Feb 15; 162(4):2384-90. PubMed ID: 9973519
    [Abstract] [Full Text] [Related]

  • 4. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response.
    Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin C, Wonigeit K, Lassmann H, Linington C.
    J Immunol; 1999 Jul 01; 163(1):40-9. PubMed ID: 10384097
    [Abstract] [Full Text] [Related]

  • 5. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN, Snyder DS.
    CRC Crit Rev Clin Neurobiol; 1984 Jul 01; 1(1):45-82. PubMed ID: 6400508
    [Abstract] [Full Text] [Related]

  • 6. Immunobiology of oligodendrocytes in multiple sclerosis.
    Ruffini F, Chojnacki A, Weiss S, Antel JP.
    Adv Neurol; 2006 Jul 01; 98():47-63. PubMed ID: 16400826
    [No Abstract] [Full Text] [Related]

  • 7. Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures.
    Besson Duvanel C, Honegger P, Matthieu JM.
    J Neurosci Res; 2001 Sep 01; 65(5):446-54. PubMed ID: 11536329
    [Abstract] [Full Text] [Related]

  • 8. To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.
    Schirmer L, Srivastava R, Hemmer B.
    Mult Scler; 2014 Mar 01; 20(3):271-9. PubMed ID: 24589684
    [Abstract] [Full Text] [Related]

  • 9. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N, Hoffman M, Mendel I, Yust I, Kaye J, Bakimer R, Flechter S, Abramsky O, Milo R, Karni A, Ben-Nun A.
    Eur J Immunol; 1997 Nov 01; 27(11):3059-69. PubMed ID: 9394837
    [Abstract] [Full Text] [Related]

  • 10. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O, Palace J, Vincent A.
    Brain; 2004 Feb 01; 127(Pt 2):269-79. PubMed ID: 14662514
    [Abstract] [Full Text] [Related]

  • 11. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin.
    Menon KK, Piddlesden SJ, Bernard CC.
    J Neurochem; 1997 Jul 01; 69(1):214-22. PubMed ID: 9202313
    [Abstract] [Full Text] [Related]

  • 12. Antibodies to oligodendroglia in patients with multiple sclerosis.
    Abramsky O, Lisak RP, Silberberg DH, Pleasure DE.
    N Engl J Med; 1977 Dec 01; 297(22):1207-11. PubMed ID: 335246
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S.
    Neurology; 2007 May 29; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
    Ichikawa M, Johns TG, Liu J, Bernard CC.
    J Immunol; 1996 Jul 15; 157(2):919-26. PubMed ID: 8752946
    [Abstract] [Full Text] [Related]

  • 15. Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis.
    Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ.
    Immunology; 2002 Dec 15; 107(4):403-10. PubMed ID: 12460184
    [Abstract] [Full Text] [Related]

  • 16. Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis.
    Berger T, Reindl M.
    J Neural Transm Suppl; 2000 Dec 15; (60):351-60. PubMed ID: 11205153
    [Abstract] [Full Text] [Related]

  • 17. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan 15; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 18. Myelin peptides in multiple sclerosis.
    Grau-López L, Raïch D, Ramo-Tello C, Naranjo-Gómez M, Dàvalos A, Pujol-Borrell R, Borràs FE, Martínez-Cáceres E.
    Autoimmun Rev; 2009 Jul 15; 8(8):650-3. PubMed ID: 19393199
    [Abstract] [Full Text] [Related]

  • 19. Neuropathology of multiple sclerosis-new concepts.
    Kornek B, Lassmann H.
    Brain Res Bull; 2003 Aug 15; 61(3):321-6. PubMed ID: 12909302
    [Abstract] [Full Text] [Related]

  • 20. [The pathogenesis of multiple sclerosis. Cytotoxic antibodies against myelin sheath tissue in multiple sclerosis].
    Frick E, Stickl H.
    Fortschr Med; 1976 Jun 10; 94(17):1019-24. PubMed ID: 964856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.